Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant
Conditions
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Recurrent Adult Acute Lymphoblastic Leukemia
- Recurrent Adult Acute Myeloid Leukemia
- Recurrent Hodgkin Lymphoma
- Recurrent Non-Hodgkin Lymphoma
- Recurrent Plasma Cell Myeloma
Interventions
- BIOLOGICAL: Therapeutic Allogeneic Lymphocytes
Sponsor
Fred Hutchinson Cancer Center
Collaborators